Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > Department of Justice Will Not Oppose Standards-Setting Organization's Proposal on Patent Information Policy

Abstract:
The Department of Justice announced today that it will not oppose a proposal by the Institute
of Electrical and Electronics Engineers Inc. (IEEE) to implement a policy on the disclosure and licensing of patents in IEEE's standards-setting process. The policy will allow patent holders to commit publicly to specific restrictions on their future licensing terms and conditions for
the use of patents that are essential to IEEE standards. The Department said that the proposed policy may enable IEEE to make better informed decisions when formulating standards that will benefit consumers.

Department of Justice Will Not Oppose Standards-Setting Organization's Proposal on Patent Information Policy

Washington, DC | Posted on April 30th, 2007

The Department's position was stated in a business review letter from
Thomas O. Barnett, Assistant Attorney General for the Department's
Antitrust Division, to counsel for IEEE and its standards association,
IEEE-SA. IEEE is a non-profit association for technology professionals with
diverse interests. IEEE-SA, IEEE's standards development organization
(SDO), develops and issues standards used in industries such as information
technology, power and energy, instrumentation and measurement, mobile and
stationary batteries, nanotechnology, organic electronics,
telecommunications, and transportation safety.

IEEE requested a business review letter from the Antitrust Division
expressing its enforcement intentions regarding a proposed patent policy
that will give holders of patents essential to IEEE standards the option of
publicly committing to the most restrictive licensing terms they would
offer. Under the policy, the patent holder could also choose a number of
other options. It could: choose not to provide any licensing information;
state that it does not believe its patents are essential to the IEEE
standard; state that it will not assert its essential patent claims against
implementors of the standard; or commit to license its essential patent
claims on reasonable and nondiscriminatory terms. The policy also clarifies
that these types of assurances about future patent licenses are
irrevocable, and that they are binding on affiliates of the patent holder.
IEEE-SA implementation of the patent policy should permit IEEE
"standard-setters" to access the relative costs of competing technologies.

In October 2006, the Department issued a business review letter to
another standard-setting organization, VMEbus International Trade
Association (VITA), in which the Department concluded that mandatory
disclosure of a patent holder's most restrictive licensing terms before a
standard is set can preserve "the benefits of competition between
alternative technologies that exist in the standard-setting process." In
the Department's letter to IEEE, Barnett said that IEEE's patent policy
"could generate similar benefits as patent holders may compete to offer the
most attractive combination of technology and licensing terms." In
addition, the increased information that may become available should
improve the decision-making of IEEE standard- setters.

"The requests from VITA and IEEE show that individual SDOs are working
to find patent disclosure and licensing policies that will improve the
efficiency of their standard-setting activities," Barnett said. "The
antitrust laws permit reasonable efforts to enhance the effectiveness of
such beneficial collaborative activities."

Under the Department's business review procedure, an organization may
submit a proposed action to the Antitrust Division and receive a statement
as to whether the Division will challenge the action under the antitrust
laws.

A file containing the business review request and the Department's
response may be examined in the Antitrust Documents Group of the Antitrust
Division, U.S. Department of Justice, Suite 215, Liberty Place, 325 7th
Street NW, Washington, DC 20530. After a 30-day waiting period, the
documents supporting the business review will be added to the file, unless
a basis for their exclusion for reasons of confidentiality has been
established under paragraph 10(c) of the Business Review Procedure, 28
C.F.R. section 50.6.

####

For more information, please click here

Copyright © PR Newswire Association LLC.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Govt.-Legislation/Regulation/Funding/Policy

Hepatitis virus-like particles as potential cancer treatment February 5th, 2016

Researchers discover new phase of boron nitride and a new way to create pure c-BN February 5th, 2016

Scientists guide gold nanoparticles to form 'diamond' superlattices: DNA scaffolds cage and coax nanoparticles into position to form crystalline arrangements that mimic the atomic structure of diamond February 4th, 2016

Polar vortices observed in ferroelectric: New state of matter holds promise for ultracompact data storage and processing February 4th, 2016

Announcements

Study reveals how herpes virus tricks the immune system February 5th, 2016

Hepatitis virus-like particles as potential cancer treatment February 5th, 2016

Organic crystals allow creating flexible electronic devices: The researchers from the Faculty of Physics of the Moscow State University have grown organic crystals that allow creating flexible electronic devices February 5th, 2016

Researchers discover new phase of boron nitride and a new way to create pure c-BN February 5th, 2016

Patents/IP/Tech Transfer/Licensing

Joint Efforts by Iranian, Malaysian Scientists Produce Antibacterial Coatings for Isolated Areas February 4th, 2016

Silicon-based metamaterials could bring photonic circuits February 1st, 2016

Therapeutic Solutions International Licenses Dexosome Clinical Stage Cancer Immunotherapy Product From Gustave Roussy European Cancer Centre: FDA Cleared Immuno-Oncology Technology to Resume Clinical Development for Solid Tumor Patients January 27th, 2016

Light-activated nanoparticles prove effective against antibiotic-resistant 'superbugs' January 19th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic